A pilot study, led by Dr. Suzanne Meiring, Dr. Annieke van Baar and Professor Jacques Bergman from the Amsterdam University Medical Center in the Netherlands has found that a single endoscopic duodenal mucosal resurfacing (DMR), along with a GLP-1 receptor agonist, can eliminate the need for insulin in most type-2 diabetes patients.
The study, which was conducted on 16 patients. found that 75% of previously insulin-dependent people with type 2 diabetes, when treated with the ablation technique did not require insulin six months later. Their HbA1c readings also fell to 7.5% or below.
Patients who responded to the treatment also saw significant reductions in their body mass index (BMI) and liver fat. This could be a breakthrough in treatment of diabetes.
Find more details here.